RETRACTABLE TECHNOLOGIES INC (RVP) Debt Components
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $895.64K; Long-Term Debt, Maturity, Year OneUSD $367.19K.
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $359.10K; Long-term Debt, Excluding Current MaturitiesUSD $623.61K; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-06-30: Long-term Debt, Current MaturitiesUSD $349.96K; Long-term Debt, Excluding Current MaturitiesUSD $717.53K; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-03-31: Long-term Debt, Current MaturitiesUSD $343.22K; Long-term Debt, Excluding Current MaturitiesUSD $807.39K; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
RETRACTABLE TECHNOLOGIES INC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Decrease, Forgiveness USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | (m) | $895.64K | $367.19K | $394.12K | $134.33K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $359.10K | $623.61K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $349.96K | $717.53K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $343.22K | $807.39K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $332.48K | $900.04K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $1.23M | $332.48K | $363.20K | $396.77K | $140.07K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $325.15K | $986.75K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $317.99K | $1.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $311.06K | $1.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $303.99K | $1.23M | $1.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $303.99K | $332.48K | $363.20K | $396.77K | $141.06K | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $297.26K | $1.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $293.54K | $1.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $287.86K | $1.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $285.95K | $1.53M | $1.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $285.95K | $308.90K | $334.42K | $361.66K | $391.12K | $137.32K | (m) | (m) | (m) | (m) |
| 2022-09-30 | $291.11K | $1.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $296.44K | $1.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $292.74K | $1.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $289.11K | $1.81M | $2.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $289.11K | $304.12K | $319.68K | $336.49K | $353.94K | $499.97K | (m) | (m) | (m) | (m) |
| 2021-09-30 | $285.52K | $1.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $281.87K | $1.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-13 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.38M |
| 2021-03-31 | $1.49M | $2.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $1.03M | $2.71M | $3.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $1.03M | $896.21K | $304.12K | $319.69K | $336.49K | $853.83K | (m) | (m) | (m) | (m) |
| 2020-09-30 | $1.10M | $2.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $874.47K | $3.00M | $1.36M | (m) | $912.83K | $298.93K | (m) | (m) | (m) | $151.24K | (m) | (m) | (m) |
| 2020-04-17 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.36M | 1.00% | (m) |
| 2020-03-31 | $264.58K | $2.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $260.94K | $2.38M | $2.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | $260.94K | $274.86K | $289.12K | $304.12K | $319.69K | $1.19M | (m) | (m) | (m) | (m) |
| 2019-09-30 | $285.71K | $2.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $322.65K | $2.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $302.36K | $2.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $406.36K | $2.64M | $3.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $406.36K | $253.28K | $268.89K | $284.99K | $302.05K | $1.53M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $424.42K | $2.73M | $2.94M | (m) | $247.00K | $260.20K | $273.70K | $287.90K | $1.81M | $63.10K | (m) | (m) | (m) |
| 2018-06-30 | $364.09K | $2.89M | $3.00M | (m) | $247.00K | $260.20K | $273.70K | $287.90K | $1.81M | $121.32K | (m) | (m) | (m) |
| 2018-03-31 | $391.65K | $2.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $410.95K | $3.08M | $3.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $410.95K | $3.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $430.09K | $3.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $440.97K | $3.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $435.65K | $3.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $430.39K | $3.50M | $3.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $430.39K | $410.95K | $3.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $259.34K | $3.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $255.96K | $3.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $252.63K | $3.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $249.35K | $3.42M | $3.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $249.35K | $262.76K | $236.05K | $2.92M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $246.11K | $3.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $154.39K | $3.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $152.05K | $3.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $149.74K | $3.43M | $3.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | $149.74K | $159.18K | $169.21K | $179.87K | $2.92M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $159.92K | $3.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $176.13K | $3.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $201.98K | $3.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $247.06K | $3.58M | $3.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $247.06K | $149.74K | $159.18K | $169.21K | $179.87K | $2.92M | (m) | (m) | (m) | (m) |
| 2013-09-30 | $279.08K | $3.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $304.49K | $3.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $319.68K | $3.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $315.09K | $3.83M | $4.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $315.09K | $247.06K | $149.74K | $159.18K | $169.21K | $3.10M | (m) | (m) | (m) | (m) |
| 2012-09-30 | $310.56K | $3.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $415.89K | $3.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $519.19K | $4.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $620.47K | $4.14M | $4.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $655.09K | $4.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $643.54K | $4.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $519.61K | $4.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |